Jason I. Herschkowitz
Baylor College of Medicine · 176 works · 9,711 citations · h-index 31
Top works
- Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
- Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
- The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
- Gene expression patterns associated with p53 status in breast cancer
- Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status
- ETV6-NTRK3 Fusion Oncogene Initiates Breast Cancer from Committed Mammary Progenitors via Activation of AP1 Complex
- Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
- FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
- Characterization of mammary tumors from Brg1 heterozygous mice
- Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
- RB1 and p53 at the crossroad of EMT and triple-negative breast cancer
- Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
- Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer
- The ups and downs of miR-205: Identifying the roles of miR-205 in mammary gland development and breast cancer
- Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
- Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
- c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer